A comprehensive view of AIDS / HIV-Positive. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Gilead Sciences reports Q3 revenue of US$7.1B was flat compared to the same period in 2022, net income attributable to Gilead of US$2.2B, up from US$1.8B a year ago; sales primarily driven by increased sales in oncology and HIV

GSK reports Q3 revenue up 4.1% to £8.15B, operating profit up 64% to £1.95B; GSK expects long-term outlook to strengthen, with progress in vaccine pipeline, the development of an ultra-long-acting HIV portfolio and new prospects in respiratory

China approves ViiV Healthcare's injectable HIV treatment consisting of Vocabria cabotegravir and Janssen's Rekambys rilpivirine; HIV affects over 1 million people in China

ViiV Healthcare to present 23 abstracts from innovative HIV treatment and prevention portfolio at 19th Annual European AIDS Conference in Warsaw, Poland from October 18-21

TaiMed Biologics advances in clinical trials with new HIV treatment, TMB-365/380 mAb combination therapy; prepares to fast-track Phase 2 trials and explore licensing and co-development opportunities after concluding successful sentinel group study

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count